Author:
Posts by Research Outreach
Crystal clear: how topography affects crystal formation
Dr Hugo Christenson is a Reader in the Molecular and Nanoscale Physics Group at the University of Leeds. His present research interests lie in crystallisation – an important process across multiple areas of science. Specifically, Dr Christenson’s work provides in-depth insight into why crystals first form in topographical defects, like cracks and crevices. Have you ever sat on a park […]
Read More… from Crystal clear: how topography affects crystal formation
From ears to engineering
Sometimes the solutions to engineering questions have already been answered – by animals! Rather than ‘reinvent the wheel,’ therefore, Professor James Windmill and his lab team at the University of Strathclyde choose to learn from some of the remarkable feats of engineering found in the natural world. In particular, his research focuses on using ideas from insect hearing to develop […]
Impaired theory of mind associated with very preterm birth – an invisible handicap
Dr Margot Taylor, Director of Functional Neuroimaging at the Hospital for Sick Children and Professor at the University of Toronto, is investigating how very preterm (VPT) birth impacts social cognitive function including Theory of Mind (ToM), a skill that enables us to appreciate that perspectives and beliefs of others can differ from our own. By using neuroimaging techniques, Dr Taylor […]
Read More… from Impaired theory of mind associated with very preterm birth – an invisible handicap
Community collaborations targeting breast cancer
Dr Marion Kavanaugh-Lynch directs the California Breast Cancer Research Program of the University of California. Her latest work with the QuickStart programme in California offers coaching for partnership teams formed between communities and academics to conduct participatory research. With a focus on the environmental factors in breast cancer and social disparities in breast cancer, she has forged an important partnership […]
Read More… from Community collaborations targeting breast cancer
Raising antibodies against protein complexes
Dr John LaCava of The Rockefeller University has identified a gap in the current availability of target-specific antibodies for the analysis of intracellular protein-protein interactions. Using the latest antibody production techniques, alongside immunoprecipitation and mass spectrometry, he aims to identify important interactions between transcription factors and other macromolecules which are implicated in disease. Proteins are vital for the inner workings […]
Read More… from Raising antibodies against protein complexes
A shining light in the fight against childhood leukaemia?
Dr C. James Lim, PhD, is an Associate Professor at the Department of Pediatrics, University of British Columbia, as well as Investigator at the Michael Cuccione Childhood Cancer Research Program at British Columbia Children’s Hospital, Vancouver, Canada. His research group aims to unravel the mechanisms underlying acquired resistance to chemotherapy in childhood malignancies, with the goal of identifying new treatment […]
Read More… from A shining light in the fight against childhood leukaemia?
Computational methods of researching cancer treatments
Artificial Intelligence (AI) and machine learning algorithms have the potential to bring substantial advances in the fields of research exploring complex diseases and trying to identify effective treatments. Dr Benjamin Haibe-Kains, working at The Princess Margaret Cancer Centre in Toronto, has spent over a decade developing machine learning tools and databases that could help scientists gain a better understanding of […]
Read More… from Computational methods of researching cancer treatments
Preventing and treating complications of heart failure and Fabry disease
Dr Gavin Y Oudit, a distinguished cardiologist from the University of Alberta, focuses his research on developing ground-breaking therapies to treat both genetic and non-genetic cardiovascular disorders, and to prevent heart failure. His exciting work into the role of ACE2 has provided a fundamental scientific understanding used in the development of therapeutic options for cardiovascular, renal and lung diseases. He […]
Read More… from Preventing and treating complications of heart failure and Fabry disease
Unravelling the cellular mechanism of spinal muscular atrophy: from gene and modifiers to therapy
Spinal muscular atrophy (SMA) is a common neuromuscular disease characterised by weakness and wasting of muscles. People with the most severe form of the disease are unable to sit or walk and die within the first two years of life. Although the genetics of SMA are well understood, the cellular mechanisms involved are unclear and there is currently no cure. […]